...
首页> 外文期刊>Cosmetic dermatology >Clindamycin Phosphate 1.2% and Benzoyl Peroxide 2.5%: A New, Once-Daily, Fixed Combination Treatment for Moderate to Severe Acne
【24h】

Clindamycin Phosphate 1.2% and Benzoyl Peroxide 2.5%: A New, Once-Daily, Fixed Combination Treatment for Moderate to Severe Acne

机译:磷酸克林霉素1.2%和过氧化苯甲酰2.5%:每日一次的新的固定组合治疗中度至重度痤疮

获取原文
获取原文并翻译 | 示例

摘要

Fixed combination products containing clindamycin and benzoyl peroxide (BPO) 5% have been shown to be effective in treating acne. However, the 5% concentration of BPO combined with inactive ingredients, such as surfactants, preservatives, and alcohols in these formulations, may contribute to skin irritation and dryness. An optimized formulation of clindamycin phosphate (CDP) and BPO using a low concentration of BPO (CDP 1.2% and BPO 2.5% gel) was developed without the use of preservatives, surfactants, or alcohol. Results of clinical studies in more than 2800 participants with moderate to severe acne demonstrated that using a once-daily, CDP 1.2% and BPO 2.5% gel is effective in the treatment of inflammatory and noninflammatory lesions of acne and is very well tolerated.
机译:已显示含有5%克林霉素和过氧化苯甲酰(BPO)的固定组合产品可有效治疗痤疮。但是,在这些配方中,浓度为5%的BPO与非活性成分(例如表面活性剂,防腐剂和酒精)混合使用可能会刺激皮肤和引起干燥。在不使用防腐剂,表面活性剂或酒精的情况下,开发了使用低浓度的BPO(CDP 1.2%和BPO 2.5%凝胶)的磷酸克林霉素和BPO的优化配方。对超过2800名中度至重度痤疮参与者的临床研究结果表明,每天一次使用1.2%的CDP和2.5%的BPO凝胶可有效治疗痤疮的炎症和非炎症性病变,并且耐受性非常好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号